Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | 20 497 | déclaré | 16 juin 2023 | tx 2+20 497 |
| Passage BIO, Inc. | 3 729 | déclaré | 08 déc. 2021 | tx 9+406 774−73 275 |
| Terns Pharmaceuticals, Inc. | 0 | déclaré | 05 mai 2026 | tx 32+261 874−290 349 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 45 000 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 10 657 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 32 000 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 3 955 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 22 000 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 32 000 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 1 697 | — | deriv |
| 01 févr. 2026 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 1 697 | 0.00 USD | deriv |
| 04 nov. 2025 | SALE | Terns Pharmaceuticals, Inc. | 24 520 | 18.00 USD | |
| 04 nov. 2025 | EXERCISE | Terns Pharmaceuticals, Inc. | 24 520 | 9.24 USD | |
| 04 nov. 2025 | EXERCISE | Terns Pharmaceuticals, Inc. | 24 520 | 0.00 USD | deriv |
| 11 juin 2025 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 45 000 | 0.00 USD | deriv |
| 01 févr. 2025 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 10 657 | 0.00 USD | deriv |
| 06 janv. 2025 | SALE | Terns Pharmaceuticals, Inc. | 8 760 | 5.79 USD | |
| 02 janv. 2025 | SALE | Terns Pharmaceuticals, Inc. | 6 240 | 5.72 USD | |
| 09 sept. 2024 | SALE | Terns Pharmaceuticals, Inc. | 17 235 | 10.00 USD | |
| 09 sept. 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 17 235 | 1.82 USD | |
| 09 sept. 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 17 235 | 0.00 USD | deriv |
| 01 août 2024 | SALE | Terns Pharmaceuticals, Inc. | 6 143 | 7.68 USD | |
| 02 août 2024 | SALE | Terns Pharmaceuticals, Inc. | 8 857 | 7.50 USD | |
| 15 juil. 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 365 | 1.82 USD | |
| 15 juil. 2024 | SALE | Terns Pharmaceuticals, Inc. | 14 365 | 10.00 USD | |
| 16 juil. 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 400 | 1.82 USD | |
| 16 juil. 2024 | SALE | Terns Pharmaceuticals, Inc. | 400 | 10.00 USD | |
| 16 juil. 2024 | EXERCISE | Terns Pharmaceuticals, Inc. | 400 | 0.00 USD | deriv |